AI could help kids with cerebral palsy get better movement assessments

NCT ID NCT07629024

Not yet recruiting Knowledge-focused Sponsor: Riphah International University Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 2 times

Summary

This study will use artificial intelligence and video analysis to assess how well children with cerebral palsy can walk and move. Researchers will collect data from 200 children aged 4 to 18 who can walk with or without help. The goal is to see if AI can accurately predict mobility and gait problems, which could lead to better, low-cost rehabilitation tools.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could lead to a low-cost, AI-based tool to help therapists better assess and track mobility in children with cerebral palsy, especially in places with limited resources.
What could go wrong: This is an early observational study, not a treatment trial. The AI model may not be accurate enough for real-world use, and results may not apply to all children with cerebral palsy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CEREBRAL PALSY CHILDREN are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cerebral palsy spastic cerebral palsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CEREBRAL PALSY CHILDREN

Contacts and locations

Locations

Alfarabi special education center

Islamabad, Pakistan
Army special education Academy

Islamabad, Pakistan
Karachi institue of neurological diseases and rehabilitation(KIND-R)

Karachi, Pakistan
National institute of Rehabilitation medicine

Islamabad, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.